The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: 0.15 (4.11%)
Spread: 0.20 (5.405%)
Open: 3.65
High: 3.80
Low: 3.65
Prev. Close: 3.65
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on development

11 Jul 2007 08:16

Fabian Romania Property Fund Ltd11 July 2007 11 July 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or "Fabian") Construction contract agreed and sales started at the New Town residential joint venture development Fabian Romania is pleased to announce that its joint venture developmentcompany, Phoenix Park SRL, has agreed a fixed price build contract with MivanKier for residential apartments at the New Town development in east Bucharest. The development project is now forecast to involve the construction of more than635 residential apartments over two phases with an estimated gross developmentvalue in excess of €120 million and total costs, excluding land, ofapproximately €80 million. The apartments will be approximately 100 squaremetres per unit and are being targeted at middle income families. Building permits have been obtained and below ground construction works areongoing with the first apartments due to be completed in the summer of 2008. A sales and marketing suite was created in central Bucharest and a full launchhas started. To date, 119 apartments with parking have been released for salecomprising the first release. City wide newspaper and radio advertising has beentaken to support the launch. In July 2006, Fabian Romania paid €5.75 million for a 50 per cent. stake in thedevelopment company. Further development funding requirements are expected to bemet by a combination of bank financing and deposits from forward sales. MivanLtd of Country Antrim, Northern Ireland, through its Romanian operating companyRopotamo Expert SRL is acting as the development manager on the project as wellas being Fabian's joint venture partner. Mark Holdsworth, Director of Fabian Capital, Fabian Romania's investment advisersaid: "We are delighted with the progress of the New Town development and ourpartners Mivan. With build costs now secured and a full sales launch underway wehave made significant progress since entering into the joint venture last year.We will provide investors with a further progress report on how well theapartments are selling at the time of the publication of our second quarter NAV,expected on Monday 23 July." Enquiries: Fabian Romania: Mark Holdsworth +44 20 7499 9988 Nominated Adviser: Deloitte & Touche LLP James Lewis +44 20 7936 3000 Broker: Shore Capital Stockbrokers Limited Dru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 202311:05 amRNSSecond Price Monitoring Extn
9th Jan 202311:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSHalf-year Report
24th Nov 20227:00 amRNSNotice of Results
31st Oct 20221:47 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSBlock admission six monthly return
23rd Sep 202211:44 amRNSResult of AGM
20th Sep 20221:36 pmRNSDirector/PDMR Shareholding
15th Sep 20223:41 pmRNSGrant of options
14th Sep 20222:05 pmRNSSecond Price Monitoring Extn
14th Sep 20222:01 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSGrant of options
1st Sep 20227:00 amRNSNotice of AGM and Director change
23rd Aug 20227:00 amRNSFinal Results
9th Aug 20227:00 amRNSBispecific designs patent application
5th Aug 20224:41 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSAppointment of Chief Executive Officer
6th May 20227:00 amRNSTrading update
1st Apr 20227:00 amRNSBlock admission six monthly return
14th Mar 20227:00 amRNSUpdate on Board changes
28th Feb 20227:00 amRNSDirector changes
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSDirectorate Change
10th Feb 202212:49 pmRNSStmnt re Share Price Movement
14th Jan 20227:00 amRNSFormation of New Scientific Advisory Panel
11th Jan 20221:26 pmRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSExercise of share options and total voting rights
14th Dec 20217:00 amRNSExercise of share options and total voting rights
6th Dec 20217:00 amRNSHalf-year Report
2nd Dec 20217:00 amRNSUpdate on R&D
17th Nov 202110:00 amRNSNotice of Results
19th Oct 20214:25 pmRNSGrant of options
7th Oct 20214:40 pmRNSSecond Price Monitoring Extn
7th Oct 20214:35 pmRNSPrice Monitoring Extension
7th Oct 20212:06 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202111:06 amRNSSecond Price Monitoring Extn
7th Oct 202111:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSNew contract win
27th Sep 20217:00 amRNSTotal Voting Rights
24th Sep 202112:00 pmRNSResult of AGM
24th Sep 20217:00 amRNSAGM Statement
1st Sep 20217:00 amRNSNotice of AGM
31st Aug 20215:00 pmRNSTotal Voting Rights
24th Aug 20217:00 amRNSCollaboration with Eurofins Discovery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.